- Home
- QGEN vs MAC Comparison
QGEN vs MAC Comparison
Compare QGEN & MAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | MAC |
|---|---|---|
| Founded | 1986 | 1964 |
| Country | Netherlands | United States |
| Employees | N/A | 2845 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 7.2B |
| IPO Year | 1998 | 1994 |
Fundamental Metrics
Financial Performance| Metric | QGEN | MAC |
|---|---|---|
| Price | $44.62 | $22.60 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | ★ $45.76 | $20.50 |
| AVG Volume (30 Days) | 1.9M | ★ 2.5M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 7.17% | 3.12% |
| EPS Growth | N/A | ★ 11.36 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,013,983,000.00 |
| Revenue This Year | $8.18 | N/A |
| Revenue Next Year | $5.71 | $4.80 |
| P/E Ratio | $24.01 | ★ N/A |
| Revenue Growth | N/A | ★ 10.43 |
| 52 Week Low | $32.53 | $16.03 |
| 52 Week High | $57.82 | $26.68 |
Technical Indicators
Market Signals| Indicator | QGEN | MAC |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 33.35 |
| Support Level | $41.34 | $22.13 |
| Resistance Level | $44.72 | $25.97 |
| Average True Range (ATR) | 0.95 | 0.48 |
| MACD | 0.07 | -0.02 |
| Stochastic Oscillator | 89.13 | 33.24 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables, with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (15%).
About MAC Macerich Company (The)
Macerich invests in premium mall assets. The company owns 27 regional malls in its consolidated portfolio and 10 regional malls in its unconsolidated portfolio along with a power center and six other real estate assets. The company's total portfolio has 39.2 million square feet of gross leasable area and averaged $899 sales per square foot over the 12 months ended in March 2026.